Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer

Abstract Ahead of Print

Navigating Alzheimer’s Disease via Chronic Stress: the Role of Glucucocorticoids

Volume:20
Vivek Kumar Sharma and Thakur Gurjeet Singh*

Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma

Volume:20
Matteo Santoni, Daniel YC Heng, Gaetano Aurilio, Andrea Iozzelli, Lucilla Servi, Andrea Fabiani, Massimo Giannini, Roberta Mazzucchelli, Alessia Cimadamore, Marina Scarpelli, Mohamed S. Zaghloul, Nicola Battelli and Rodolfo Montironi*

Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas

Volume:20
Cécile Le Page*, Jacqueline Chung, Kurosh Rahimi, Martin Kobel, Diane Provencher and Anne- Marie Mes- Masson

Study of Monocytes/Macrophages Stimuli as the Targets of Treating Inflammatory Bone Diseases

Volume:20
Yuan Liu, Yang Cao, Wanli Smith, Baorong He and Liang Yan*

Neutrophilic Asthma and Potentially Related Target Therapies

Volume:20
Pranav Nair* and Kedar S Prabhavalkar

Study of natural compounds target RANKL signaling pathway for treating bone diseases

Volume:20
Chang Liu, Yuan He, Xiaobing Xu, Lijun He, Baorong He and Lingbo Kong*